$2.3 Billion Pharmaceutical Acquisition

Cleary Gottlieb is representing Goldman Sachs, as financial advisor to Mallenkrodt Pharmaceuticals in its all-cash acquisition of Ikaria, Inc. The transaction is valued at approximately $2.3 billion. The deal signed on February 5, 2015 and is expected to close early in the second quarter of 2015.

Mallenkrodt is a global specialty biopharmaceutical and medical imaging business that develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents.

Ikaria is a global critical care company focused on development and commercialization of innovative therapies and delivery systems to address the needs of critically ill infants in hospital neonatal intensive care unit settings.